Change takes time. Particularly in the life sciences, where a single drug’s journey from idea to market can consist of more than a decade of small, yet critical steps. For New York, then, aspirations to become a region known for its biotech industry are—and always have been—a long game in which every year and bit […]
NYS Entity Status
NYS Filing Date
JULY 16, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC REGISTERED LIMITED LIABILITY PARTNERSHIP
2013 - MARQUART & SMALL LLP
Around the Web
- What Steps Should NY Biotech Take in 2018? Share Your View on Dec. 11
By Ben Fidler - Monday Nov 20, 2017
- Julius Caesar was much ado over nothing
By Charles Gross - Friday Jun 23, 2017
The Public Theater should get down on its knees and thank Breitbart, Fox News, Bank of America and Delta Airlines. Because of them, the Public’s production of Julius Caesar in Central Park, an...
To view the full story, click the title link.
- Art Gallery Closures Grow for Small and Midsize Dealers
By ROBIN POGREBIN - Monday Jun 26, 2017
Large galleries with multiple locations grab wider audiences, dominate art fairs and focus on trophy works. Closures threaten emerging artists.
- Police Officer Found Not Guilty in Off-Duty Shooting of Unarmed Man
By ASHLEY SOUTHALL - Monday Nov 6, 2017
Jurors weighed whether Officer Wayne Isaacs had a duty to retreat from a confrontation with Delrawn Small. Defense lawyers said he had the right to defend himself.
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]